COVID 19 Nasal Vaccine Market Analysis, Trends, Forecast Up to 2030

The Global COVID 19 Nasal Vaccine Market Size is expected to reach USD xx billion by 2030, at a CAGR of x.x% during the forecast period 2022 to 2030. The COVID 19 Nasal Vaccine is only intended for use in emergency situations and is intended for primary immunisation against COVID-19 in the 18+ age group. Nasal vaccines are a better option than traditional shots for kids and adults with trypanophobia, or a fear of needles.